The down-regulated expression of EPHA5 observed in sALS fibroblasts is in line with previous findings implicating ephrin-A5 as a modifier of disease progression in both ALS patients and animal models [87]. This evidence concerns the gene EPHA5 and amyotrophic lateral sclerosis.